サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1322226

脊椎バイオロジクス市場：世界の業界分析、規模、シェア、成長、動向、および予測、2023年から2031年

Spine Biologics Market (Product: Bone Allografts, Bone Graft Substitute, Platelet Rich Plasma, Bone Marrow Aspirate Therapy, Demineralized Bone Matrix (DBM), and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日: | 発行: Transparency Market Research | ページ情報: 英文 190 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
脊椎バイオロジクス市場：世界の業界分析、規模、シェア、成長、動向、および予測、2023年から2031年
出版日: 2023年06月15日
発行: Transparency Market Research
ページ情報: 英文 190 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

脊椎バイオロジクス市場- レポートの範囲

世界の脊椎バイオロジクス市場に関するTMRのレポートは、過去と現在の成長動向、および2023年から2031年の予測期間中に市場の指標の貴重な洞察を得る機会を研究しています。このレポートは、2023年を基準年、2031年を予測年とし、2017年から2031年までの世界市場の収益を提供します。また、2023年から2031年までの世界市場の複合年間成長率（CAGR %）も提供します。

このレポートは広範な調査を経て作成されました。1次調査では、調査活動の大部分が行われ、アナリストが主要なオピニオンリーダー、業界リーダー、オピニオンメーカーにインタビューを実施しました。2次調査には、脊椎バイオロジクス市場を理解するために、主要企業の製品文献、年次報告書、プレスリリース、および関連文書の参照が含まれます。

このレポートは、世界の脊椎バイオロジクス市場の競合情勢を詳しく掘り下げています。世界の脊椎バイオロジクス市場で活動している主要プレーヤーが特定され、これらのそれぞれがさまざまな属性の観点からプロファイルされています。会社概要、財務状況、最近の動向、 SWOTは、このレポートで紹介されている世界の脊椎バイオロジクス市場のプレーヤーの属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界市場の分析と予測、2017～2031年
  • ポーターのファイブフォース分析

第5章 重要な洞察

  • 技術の進歩
  • 地域/世界ごとの償還シナリオ
  • 地域/世界ごとの規制シナリオ
  • パイプライン分析
  • COVID-19感染症パンデミックによる業界への影響（バリューチェーンと短期・中期・長期的な影響）

第6章 世界市場の分析と予測：製品別

  • イントロダクションと定義
  • 主な発見/開発
  • 市場価値予測：製品別、2017-2031
    • 同種骨移植片
    • 骨移植片代替品
    • 多血小板血漿
    • 骨髄吸引療法
    • 脱灰骨マトリックス（DBM）
    • その他
  • 市場魅力度分析：製品別

第7章 世界市場の分析と予測：外科手術タイプ別

  • イントロダクションと定義
  • 主な発見/開発
  • 市場価値予測：外科手術タイプ別、2017-2031
    • 低侵襲手術
    • 開腹手術
  • 市場魅力度分析：外科手術タイプ別

第8章 世界市場の分析と予測：用途別

  • イントロダクションと定義
  • 主な発見/開発
  • 市場価値予測：用途別、2017-2031
    • 脊椎固定術
    • 脊椎癒合不全および骨折の修復
    • 椎間板変性疾患の治療
    • その他の用途
  • 市場魅力分析：用途別

第9章 世界市場の分析と予測：エンドユーザー別

  • イントロダクションと定義
  • 主な発見/開発
  • 市場価値予測：エンドユーザー別、2017-2031
    • 病院
    • 脊椎外科センター
    • その他
  • 市場魅力度分析：エンドユーザー別

第10章 世界市場の分析と予測：地域別

  • 主な調査結果
  • 市場価値予測：地域別、2017-2031
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場魅力度分析：地域別

第11章 北米市場の分析と予測

第12章 欧州市場の分析と予測

第13章 アジア太平洋市場の分析と予測

第14章 ラテンアメリカ市場の分析と予測

第15章 中東およびアフリカ市場の分析と予測

第16章 競合情勢

  • 市場プレーヤー-競合マトリックス（企業の階層および規模別）
  • 市場シェア分析：企業別、2022年
  • 企業プロファイル
    • Johnson And Johnson（Depuy Synthes）
    • Orthofix Medical Inc.
    • Stryker Corporation
    • Zimmer Biomet
    • Arthrex, Inc.
    • Exactech, Inc.
    • Spine Wave, Inc.
    • Medtronic plc
    • NuVasive, Inc.
図表

List of Tables

  • Table 01: Global Spine Biologics Market Value (US$ Mn) Forecast, by Product, 2022 and 2031
  • Table 02: Global Spine Biologics Market Value (US$ Mn) Forecast, by Surgery Type, 2017-2031
  • Table 03: Global Spine Biologics Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 04: Global Spine Biologics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 05: Global Spine Biologics Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 06: North America Spine Biologics Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 07: North America Spine Biologics Market Value (US$ Mn) Forecast, by Surgery Type, 2017-2031
  • Table 08: North America Spine Biologics Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 09: North America Spine Biologics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 10: North America Biologics Market Value Share Analysis, by Country, 2022 and 2031
  • Table 11: Europe Spine Biologics Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 12: Europe Spine Biologics Market Value (US$ Mn) Forecast, by Surgery Type, 2017-2031
  • Table 13: Europe Spine Biologics Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 14: Europe Spine Biologics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 15: Asia Pacific Spine Biologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 16: Asia Pacific Spine Biologics Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 17: Asia Pacific Spine Biologics Market Value (US$ Mn) Forecast, by Surgery Type, 2017-2031
  • Table 18: Asia Pacific Spine Biologics Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 19: Asia Pacific Spine Biologics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 20: Latin America Spine Biologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 21: Latin America Spine Biologics Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 22: Latin America Spine Biologics Market Value (US$ Mn) Forecast, by Surgery Type, 2017-2031
  • Table 23: Latin America Spine Biologics Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 24: Latin America Spine Biologics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 25: Middle East & Africa Spine Biologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 26: Middle East & Africa Spine Biologics Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 27: Middle East & Africa Spine Biologics Market Value (US$ Mn) Forecast, by Surgery Type, 2017-2031
  • Table 28: Middle East & Africa Spine Biologics Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 29: Middle East & Africa Spine Biologics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Spine Biologics Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 02: Global Spine Biologics Market Attractiveness Analysis, Product, 2023-2031
  • Figure 03: Global Spine Biologics Market Revenue (US$ Mn), by Bone Allografts, 2017-2031
  • Figure 04: Global Spine Biologics Market Revenue (US$ Mn), by Bone Graft Substitute, 2017-2031
  • Figure 05: Global Spine Biologics Market Revenue (US$ Mn), by Platelet Rich Plasma, 2017-2031
  • Figure 06: Global Spine Biologics Market Revenue (US$ Mn), by Bone Marrow Aspirate Therapy, 2017-2031
  • Figure 07: Global Spine Biologics Market Revenue (US$ Mn), by Demineralized Bone Matrix (DBM), 2017-2031
  • Figure 08: Global Spine Biologics Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 09: Global Spine Biologics Market Value Share Analysis, by Surgery Type, 2022 and 2031
  • Figure 10: Global Spine Biologics Market Attractiveness Analysis, by Surgery Type, 2023-2031
  • Figure 11: Global Spine Biologics Market Revenue (US$ Mn), by Minimally Invasive Surgery, 2017-2031
  • Figure 12: Global Spine Biologics Market Revenue (US$ Mn), by Open Surgery, 2017-2031
  • Figure 13: Global Spine Biologics Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 14: Global Spine Biologics Market Attractiveness Analysis, Application, 2023-2031
  • Figure 15: Global Spine Biologics Market Revenue (US$ Mn), by Spinal Fusion, 2017-2031
  • Figure 16: Global Spine Biologics Market Revenue (US$ Mn), by Spinal Non-union & Fracture Repair, 2017-2031
  • Figure 17: Global Spine Biologics Market Revenue (US$ Mn), by Degenerative Disc Disease Treatment, 2017-2031
  • Figure 18: Global Spine Biologics Market Revenue (US$ Mn), by Other Applications, 2017-2031
  • Table 19: Europe Spine Biologics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Figure 20: Global Spine Biologics Market Attractiveness Analysis, End-user, 2023-2031
  • Figure 21: Global Spine Biologics Market Revenue (US$ Mn), by Hospitals, 2017-2031
  • Figure 22: Global Spine Biologics Market Revenue (US$ Mn), by Spinal Surgery Centers, 2017-2031
  • Figure 23: Global Spine Biologics Market Revenue (US$ Mn), by Others
  • Figure 24: Global Spine Biologics Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 25: Global Spine Biologics Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 26: North America Spine Biologics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 27: North America Spine Biologics Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 28: North America Spine Biologics Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 29: North America Spine Biologics Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 30: North America Spine Biologics Market Attractiveness Analysis, Product, 2023-2031
  • Figure 31: North America Spine Biologics Market Value Share Analysis, by Surgery Type, 2022 and 2031
  • Figure 32: North America Spine Biologics Market Attractiveness Analysis, Surgery Type, 2023-2031
  • Figure 33: North America Spine Biologics Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 34: North America Spine Biologics Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 35: North America Spine Biologics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 36: North America Spine Biologics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 37: Europe Spine Biologics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 38: Europe Spine Biologics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 39: Europe Spine Biologics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 40: Europe Spine Biologics Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 41: Europe Spine Biologics Market Attractiveness Analysis, Product, 2023-2031
  • Figure 42: Europe Spine Biologics Market Value Share Analysis, by Surgery Type, 2022 and 2031
  • Figure 43: Europe Spine Biologics Market Attractiveness Analysis, by Surgery Type, 2023-2031
  • Figure 44: Europe Spine Biologics Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 45: Europe Spine Biologics Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 46: Europe Spine Biologics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 47: Europe Spine Biologics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 48: Asia Pacific Spine Biologics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 49: Asia Pacific Spine Biologics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 50: Asia Pacific Spine Biologics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 51: Asia Pacific Spine Biologics Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 52: Asia Pacific Spine Biologics Market Attractiveness Analysis, Product, 2023-2031
  • Figure 53: Asia Pacific Spine Biologics Market Value Share Analysis, by Surgery Type, 2022 and 2031
  • Figure 54: Asia Pacific Spine Biologics Market Attractiveness Analysis, by Surgery Type, 2023-2031
  • Figure 55: Asia Pacific Spine Biologics Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 56: Asia Pacific Spine Biologics Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 57: Asia Pacific Spine Biologics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 58: Asia Pacific Spine Biologics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 59: Latin America Spine Biologics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 60: Latin America Spine Biologics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 61: Latin America Spine Biologics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 62: Latin America Spine Biologics Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 63: Latin America Spine Biologics Market Attractiveness Analysis, Product, 2023-2031
  • Figure 64: Latin America Spine Biologics Market Value Share Analysis, by Surgery Type, 2022 and 2031
  • Figure 65: Latin America Spine Biologics Market Attractiveness Analysis, Surgery Type, 2023-2031
  • Figure 66: Latin America Spine Biologics Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 67: Latin America Spine Biologics Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 68: Latin America Spine Biologics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 69: Latin America Spine Biologics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 70: Middle East & Africa Spine Biologics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 71: Middle East & Africa Spine Biologics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 72: Middle East & Africa Spine Biologics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 73: Middle East & Africa Spine Biologics Market Value Share Analysis, by Product 2022 and 2031
  • Figure 74: Middle East & Africa Spine Biologics Market Attractiveness Analysis, Product, 2023-2031
  • Figure 75: Middle East & Africa Spine Biologics Market Value Share Analysis, by Surgery Type, 2022 and 2031
  • Figure 76: Middle East & Africa Spine Biologics Market Attractiveness Analysis, Surgery Type, 2023-2031
  • Figure 77: Middle East & Africa Spine Biologics Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 78: Middle East & Africa Spine Biologics Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 79: Middle East & Africa Spine Biologics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 80: Middle East & Africa Spine Biologics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 81: Global Spine Biologics Market Share Analysis, by Company 2022
目次
Product Code: TMRGL17444

Spine Biologics Market - Scope of Report

TMR's report on the global Spine Biologics Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Spine Biologics Market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Spine Biologics Market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Spine Biologics Market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Spine Biologics Market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Spine Biologics Market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Spine Biologics Market.

The report delves into the competitive landscape of the global Spine Biologics Market. Key players operating in the global Spine Biologics Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Spine Biologics Market profiled in this report.

Key Questions Answered in Global Spine Biologics Market Report:

  • What is the sales/revenue generated by mobile photo printer across all regions during the forecast period?
  • What are the opportunities in the global Spine Biologics Market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Spine Biologics Market - Research Objectives and Research Approach

The comprehensive report on the global Spine Biologics Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Spine Biologics Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Spine Biologics.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Spine Biologics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Spine Biologics Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)
  • 4.5. Porter's Five Forces Analysis

5. Key Insights

  • 5.1. Technological Advancements
  • 5.2. Reimbursement Scenario by Region/Globally
  • 5.3. Regulatory Scenario by Region/Globally
  • 5.4. Pipeline Analysis
  • 5.5. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)

6. Global Spine Biologics Market Analysis and Forecast, by Product

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product, 2017-2031
    • 6.3.1. Bone Allografts
    • 6.3.2. Bone Graft Substitute
    • 6.3.3. Platelet Rich Plasma
    • 6.3.4. Bone Marrow Aspirate Therapy
    • 6.3.5. Demineralized Bone Matrix (DBM)
    • 6.3.6. Others
  • 6.4. Market Attractiveness Analysis, by Product

7. Global Spine Biologics Market Analysis and Forecast, by Surgery Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Surgery Type, 2017-2031
    • 7.3.1. Minimally Invasive Surgery
    • 7.3.2. Open Surgery
  • 7.4. Market Attractiveness Analysis, by Surgery Type

8. Global Spine Biologics Market Analysis and Forecast, by Application

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Application, 2017-2031
    • 8.3.1. Spinal Fusion
    • 8.3.2. Spinal Non-union & Fracture Repair
    • 8.3.3. Degenerative Disc Disease Treatment
    • 8.3.4. Other Applications
  • 8.4. Market Attractiveness Analysis, by Application

9. Global Spine Biologics Market Analysis and Forecast, by End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by End-user, 2017-2031
    • 9.3.1. Hospitals
    • 9.3.2. Spinal Surgery Centers
    • 9.3.3. Others
  • 9.4. Market Attractiveness Analysis, by End-user

10. Global Spine Biologics Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2017-2031
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness Analysis, by Region

11. North America Spine Biologics Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product, 2017-2031
    • 11.2.1. Bone Allografts
    • 11.2.2. Bone Graft Substitute
    • 11.2.3. Platelet Rich Plasma
    • 11.2.4. Bone Marrow Aspirate Therapy
    • 11.2.5. Demineralized Bone Matrix (DBM)
    • 11.2.6. Others
  • 11.3. Market Value Forecast, by Surgery Type, 2017-2031
    • 11.3.1. Minimally Invasive Surgery
    • 11.3.2. Open Surgery
  • 11.4. Market Value Forecast, by Application, 2017-2031
    • 11.4.1. Spinal Fusion
    • 11.4.2. Spinal Non-union & Fracture Repair
    • 11.4.3. Degenerative Disc Disease Treatment
    • 11.4.4. Other Applications
  • 11.5. Market Value Forecast, by End-user, 2017-2031
    • 11.5.1. Hospitals
    • 11.5.2. Spinal Surgery Centers
    • 11.5.3. Others
  • 11.6. Market Value Forecast, by Country, 2017-2031
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Product
    • 11.7.2. By Surgery Type
    • 11.7.3. By Application
    • 11.7.4. By End-user
    • 11.7.5. By Country

12. Europe Spine Biologics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product, 2017-2031
    • 12.2.1. Bone Allografts
    • 12.2.2. Bone Graft Substitute
    • 12.2.3. Platelet Rich Plasma
    • 12.2.4. Bone Marrow Aspirate Therapy
    • 12.2.5. Demineralized Bone Matrix (DBM)
    • 12.2.6. Others
  • 12.3. Market Value Forecast, by Surgery Type, 2017-2031
    • 12.3.1. Minimally Invasive Surgery
    • 12.3.2. Open Surgery
  • 12.4. Market Value Forecast, by Application, 2017-2031
    • 12.4.1. Spinal Fusion
    • 12.4.2. Spinal Non-union & Fracture Repair
    • 12.4.3. Degenerative Disc Disease Treatment
    • 12.4.4. Other Applications
  • 12.5. Market Value Forecast, by End-user, 2017-2031
    • 12.5.1. Hospitals
    • 12.5.2. Spinal Surgery Centers
    • 12.5.3. Others
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Product
    • 12.7.2. By Surgery Type
    • 12.7.3. By Application
    • 12.7.4. By End-user
    • 12.7.5. By Country/Sub-region

13. Asia Pacific Spine Biologics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product, 2017-2031
    • 13.2.1. Bone Allografts
    • 13.2.2. Bone Graft Substitute
    • 13.2.3. Platelet Rich Plasma
    • 13.2.4. Bone Marrow Aspirate Therapy
    • 13.2.5. Demineralized Bone Matrix (DBM)
    • 13.2.6. Others
  • 13.3. Market Value Forecast, by Surgery Type, 2017-2031
    • 13.3.1. Minimally Invasive Surgery
    • 13.3.2. Open Surgery
  • 13.4. Market Value Forecast, by Application, 2017-2031
    • 13.4.1. Spinal Fusion
    • 13.4.2. Spinal Non-union & Fracture Repair
    • 13.4.3. Degenerative Disc Disease Treatment
    • 13.4.4. Other Applications
  • 13.5. Market Value Forecast, by End-user, 2017-2031
    • 13.5.1. Hospitals
    • 13.5.2. Spinal Surgery Centers
    • 13.5.3. Others
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Product
    • 13.7.2. By Surgery Type
    • 13.7.3. By Application
    • 13.7.4. By End-user
    • 13.7.5. By Country/Sub-region

14. Latin America Spine Biologics Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product, 2017-2031
    • 14.2.1. Bone Allografts
    • 14.2.2. Bone Graft Substitute
    • 14.2.3. Platelet Rich Plasma
    • 14.2.4. Bone Marrow Aspirate Therapy
    • 14.2.5. Demineralized Bone Matrix (DBM)
    • 14.2.6. Others
  • 14.3. Market Value Forecast, by Surgery Type, 2017-2031
    • 14.3.1. Minimally Invasive Surgery
    • 14.3.2. Open Surgery
  • 14.4. Market Value Forecast, by Application, 2017-2031
    • 14.4.1. Spinal Fusion
    • 14.4.2. Spinal Non-union & Fracture Repair
    • 14.4.3. Degenerative Disc Disease Treatment
    • 14.4.4. Other Applications
  • 14.5. Market Value Forecast, by End-user, 2017-2031
    • 14.5.1. Hospitals
    • 14.5.2. Spinal Surgery Centers
    • 14.5.3. Others
  • 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Product
    • 14.7.2. By Surgery Type
    • 14.7.3. By Application
    • 14.7.4. By End-user
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa Spine Biologics Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Product, 2017-2031
    • 15.2.1. Bone Allografts
    • 15.2.2. Bone Graft Substitute
    • 15.2.3. Platelet Rich Plasma
    • 15.2.4. Bone Marrow Aspirate Therapy
    • 15.2.5. Demineralized Bone Matrix (DBM)
    • 15.2.6. Others
  • 15.3. Market Value Forecast, by Surgery Type, 2017-2031
    • 15.3.1. Minimally Invasive Surgery
    • 15.3.2. Open Surgery
  • 15.4. Market Value Forecast, by Application, 2017-2031
    • 15.4.1. Spinal Fusion
    • 15.4.2. Spinal Non-union & Fracture Repair
    • 15.4.3. Degenerative Disc Disease Treatment
    • 15.4.4. Other Applications
  • 15.5. Market Value Forecast, by End-user, 2017-2031
    • 15.5.1. Hospitals
    • 15.5.2. Spinal Surgery Centers
    • 15.5.3. Others
  • 15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Product
    • 15.7.2. By Surgery Type
    • 15.7.3. By Application
    • 15.7.4. By End-user
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (by tier and size of companies)
  • 16.2. Market Share Analysis, by Company, 2022
  • 16.3. Company Profiles
    • 16.3.1. Johnson And Johnson (Depuy Synthes)
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Orthofix Medical Inc.
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. Stryker Corporation
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Zimmer Biomet
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Arthrex, Inc.
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Exactech, Inc.
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Spine Wave, Inc.
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Medtronic plc
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. NuVasive, Inc.
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview